PROTALIX BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.15 USD | -2.54% |
|
0.00% | -35.39% |
| Mar. 14 | Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024 | |
| Mar. 14 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Protalix BioTherapeutics, Inc.
f0b1f22023c063f25e030f2f135.eunF3mD6O43iQDwLH3W3xTUXjbSoQWPpki6kBBDDKG4.KrC0pDKoUu-WLXZKUgL1qE9NzNnGKRbZ6kfBd2WRSwVCn7OBU4NR_pIhCA~d85675e25f09936fd43e9cc1b60c6e94
Upcoming events on Protalix BioTherapeutics, Inc.
Past events on Protalix BioTherapeutics, Inc.
| 2024-03-14 08:30 am | Q4 2023 Earnings Call |
| 2024-03-14 06:50 am | Q4 2023 Earnings Release |
| 2024-02-26 01:00 pm | BIO CEO & Investor Conference |
| 2023-11-06 08:30 am | Q3 2023 Earnings Call |
| 2023-11-06 06:50 am | Q3 2023 Earnings Release |
| 2023-09-13 03:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-09 03:30 pm | Canaccord Genuity Growth Conference |
| 2023-08-07 08:30 am | Q2 2023 Earnings Call |
| 2023-08-07 06:50 am | Q2 2023 Earnings Release |
| 2023-06-28 08:30 am | Annual General Meeting |
| 2023-06-27 08:00 am | Investor Meeting |
| 2023-05-04 08:30 am | Q1 2023 Earnings Call |
| 2023-05-04 06:50 am | Q1 2023 Earnings Release |
| 2023-02-27 08:30 am | Q4 2022 Earnings Call |
| 2023-02-27 06:50 am | Q4 2022 Earnings Release |
| 2023-02-21 | WORLD Symposium |
| 2022-12-05 08:30 am | Investor Meeting - Key Opinion Leader |
| 2022-11-14 08:30 am | Q3 2022 Earnings Call |
| 2022-11-14 06:50 am | Q3 2022 Earnings Release |
| 2022-09-14 11:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,9 16,5 -3.61% | 16,2 35,1 -53.76% | 38,4 37,6 2.02% | 47,6 45,1 5.53% | 65,5 64,0 2.41% | 74,1 |
|
EBITDA Million USD | Released Forecast Spread | -9,10 -18,7 51.34% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,7 -20,4 47.47% | 2,71 -1,44 288.06% | -20,5 -18,5 -10.83% | -13,0 -18,2 28.44% | 10,5 11,5 -9.12% | 20,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,3 -28,0 34.73% | -6,52 -10,0 34.98% | -27,6 -26,0 -5.99% | -14,4 -18,8 23.43% | 8,57 9,56 -10.41% | 17,7 |
|
Net income Million USD | Released Forecast Spread | -18,3 -28,0 34.73% | -6,52 -10,0 34.98% | -27,6 -26,0 -5.99% | -14,9 -18,8 20.61% | 8,31 8,12 2.31% | 17,7 |
|
EPS USD | Released Forecast Spread | -1,23 -1,88 34.57% | -0,22 -0,34 34.33% | -0,62 -0,59 -5.08% | -0,31 -0,39 20.51% | 0,09 0,11 -14.29% | 0,21 |
| Announcement Date | 12/03/20 | 30/03/21 | 31/03/22 | 27/02/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,55 7,79 9.74% | 8,75 2,68 227.21% | 14,2 5,70 149.04% | 8,62 6,12 40.8% | 35,1 10,2 243.13% | 10,3 7,64 35.41% | 10,5 8,15 28.73% | 9,20 | 8,90 | 10,5 | 21,6 | ||
|
EBIT Million USD | Released Forecast Spread | -5,71 -3,71 -53.93% | -5,52 -8,72 36.62% | -3,13 -7,38 57.67% | -2,50 -7,67 67.45% | 20,4 -1,82 1223.27% | -1,89 -3,77 49.89% | -5,62 -1,57 -257.19% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,67 -5,11 -30.55% | -5,33 -8,67 38.44% | -3,57 -7,33 51.36% | -3,21 -7,62 57.85% | 19,6 -2,47 896.07% | -1,72 -4,75 63.82% | -6,43 -1,87 -243.27% | ||||||
|
Net income Million USD | Released Forecast Spread | -6,67 -5,11 -30.55% | -2,29 | -5,33 -8,67 38.44% | -3,57 -7,33 51.36% | -3,74 -7,62 50.89% | -3,13 | 19,3 -2,47 883.59% | -1,85 -4,75 61.02% | -6,04 -1,87 -222.86% | ||||
|
EPS USD | Released Forecast Spread | -0,14 -0,11 -27.27% | -0,05 | -0,11 -0,18 38.89% | -0,07 -0,15 53.33% | -0,07 -0,15 53.33% | -0,05 | 0,21 -0,04 625% | -0,03 -0,07 57.14% | -0,07 -0,03 -180% | -0,02 | -0,02 | 0,00 | 0,13 |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 27/02/23 | 04/05/23 | 07/08/23 | 06/11/23 | 14/03/24 | - | - | - | - |
More events
Past sector events for Protalix BioTherapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PLX Stock
- Calendar Protalix BioTherapeutics, Inc.
